- Lobbying
- glaxosmithkline
Lobbying Arrangements Results for 'Glaxosmithkline'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details |
GLAXOSMITHKLINE CONSUMER HEALTHCARE
|
ROPES & GRAY LLP | |||
Details Payment for drugs under Medicare outpatient PPS and Part D |
GLAXOSMITHKLINE
|
HEALTH POLICY ALTERNATIVES | |||
Details Legislation related to intellectual property |
GLAXOSMITHKLINE
|
KENT & O'CONNOR, INCORPORATED | |||
Details Issues related to prescription drugs. |
GlaxoSmithKline, Inc.
|
Sims Strategies, LLC | |||
Details General health industry issues and pharmaceutical issues impacting GSK. |
GlaxoSmithKline LLC
Pharmaceutical Company. |
LMH STRATEGIC SOLUTIONS | |||
Details Biothreats; HR 3299; Strengthening public health emergency response act |
GlaxoSmithKline
Pharmaceutical Manufacturer |
Prime Policy Group | |||
Details Chronic disease management. |
GlaxoSmithKline
A pharmaceutical company. |
DC NAVIGATORS LLC | |||
Details Implementation of H.R.5376 - Inflation Reduction Act of 2022. H.R.5378 - Lower Costs, More Transparency Act. |
GlaxoSmithKline
|
W Strategies, LLC | |||
Details Education around access to innovative cancer therapies. |
TESARO, Inc.
|
W Strategies, LLC | |||
Details Drug pricing and access, and Medicare and Medicaid reimbursement Issues related to pharmaceutical industry, generally Drug pricing and access, and Medicare and Medicaid reimbursement |
Glaxosmithkline, Inc.
|
RICCHETTI INCORPORATED | |||
Details Support increased funding for the CDC National Immunization Program (sec 317 program) |
GlaxoSmithKline
|
Cornerstone Government Affairs, LLC | |||
Details General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pa... |
GlaxoSmithKline
|
East End Group, LLC | |||
Details Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program, noninterference, and importation. Issues related to bio health security and vacci... |
GlaxoSmithKline, Inc.
|
Chamber Hill Strategies | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
GlaxoSmithKline
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Health Care Reform and Reimportation. H.R.3200/S.1679, H.R.3692, H.R.3590 H.R.1, American Recovery and Reinvestment Act of 2009 and Reimportation. H.R.2, Children's Health Insurance Program Reautho... |
GlaxoSmithKline
|
BKSH & ASSOCIATES | |||
Details S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementatio... |
GlaxoSmithKline
pharmaceutical company |
FOLEY HOAG LLP | |||
Details Monitor Patent issues Corporate Tax Reform Excise Tax Issues Health Care Extenders USTR appointments Patent Protection NAFTA repeal and Renegotiation Health Care Reform Legislation HR1628 Access to... |
GlaxoSmithKline
|
Policy Advocates | |||
Details Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. |
GlaxoSmithKline LLC
|
Capitol Counsel LLC | |||
Details General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and... |
GlaxoSmithKline LLC
|
Thorn Run Partners | |||
Details Enforcement priorities and policies regarding communications by pharmaceutical and medical device manufacturers about their medical products. |
Medical Information Working Group
|
Ropes & Gray, LLP | |||
Details Modernizing criminal sentencing concerning theft of medical products |
Coalition for Patient Safety and Medicine Integrity
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to healthcare and payment for over-the-counter drugs; FY2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations and FY2025 Departments ... |
Haleon US Holdings LLC (ffa GlaxoSmithKline Consumer Healthcare DBA Haleon)
|
Crossroads Strategies, LLC | |||
Details FY24 DOD appropriations and medical research Issues related to prescription drug pricing Issues related to Pharmacy Benefit Managers Implementation of the Inflation Reduction Act (PL 117-169) Issue... |
GlaxoSmithKline LLC
|
ALPINE GROUP PARTNERS, LLC. | |||
Details Monitor and educate policymakers on issues related to the pharmaceutical industry, including efforts to reform prescription drug pricing in the U.S.; educate Members on efforts to develop a vaccine... |
GlaxoSmithKline LLC
|
Invariant LLC | |||
Details Pharmaceutical import safety legislation Implementation of the Patient Protection and Affordable Health Care Act H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187, Food and Drug A... |
GlaxoSmithKline
|
BOCKORNY GROUP, INC. | |||
Details Drug pricing issues |
GlaxoSmithKline
|
JST Strategies LLC (Jochum Shore & Trossevin PC) | |||
Details S. 570 Medicaid Dental Benefit Act; appropriations report language for oral health, smoking cessation, public health funding and medically necessary dental care under Medicare; coverage for dietary... |
GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON
|
Venable LLP | |||
Details DOJ policy regarding off label communications. |
Medical Information Working Group
|
SIDLEY AUSTIN LLP | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Tobacco Cessation; E-cigarette regulation; S. 2622 - Quit Because of COVID Act; H.R. 5546 - PROTECT Act; H.R. 6286 - Clarifying Authority Over Nicotine Act. Dietary Supplement Eligible Expenses und... |
GlaxoSmithKline Consumer Healthcare
|
Faegre Drinker Biddle & Reath LLP | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
GSK (fka GLAXOSMITHKLINE INC.)
|
in-house lobbying | |||
Details General review and monitoring of legislative and regulatory proposals impacting Infrastructure Investment and Jobs Act (P.L. 117-58), and the Inflation Reduction Act of 2022 (P.L. 117-169) General ... |
Haleon US Holdings LLC
|
in-house lobbying | |||
Details Implementation of PPACA. Patent Reform Act and Patent Trademark Office Fee Modernization Act. Monitor federal legislation related to patent reform and other health care issues and advise client as ... |
GLAXOSMITHKLINE
|
DUTKO WORLDWIDE, LLC |